Environmental/Airborne Allergy News

WASHINGTON — Attending daycare early in life had a protective effect against sensitization to perennial aeroallergens, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Allergic respiratory symptoms consistently had stronger associations with Phl p 5 grass allergen than with grass pollen counts in a study published in The Journal of Allergy and Clinical Immunology.

ANAHEIM, Calif. — An artificial intelligence model counted and classified grains of pollen almost as accurately as a human being, according to a poster at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — Patients with asthma can remediate mold damage in their homes after flooding caused by natural disasters, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

ANAHEIM, Calif. — ChatGPT answered accurately or somewhat accurately 91% of the time when asked about 10 allergy myths, according to a study presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Healio compiled the most-read news in allergy, asthma and immunology posted in October.

More than 200 health journals simultaneously published an editorial calling on the United Nations, political leaders and health professionals to recognize how climate change and biodiversity are a single global health emergency.

HONOLULU — As global warming progresses, advocacy by clinicians who can speak about the health impacts of rising temperatures is crucial in evoking change, according to a presentation at the CHEST Annual Meeting.

A four-step rush-induction protocol ending with 0.05 mL of the 1:10 v/v concentration was safe for patients at the beginning of aeroallergen therapy, according to a letter published in Annals of Allergy, Asthma & Immunology.

Patients with cat allergies experienced improvements in their symptoms with twice-daily use of a holo beta-lactoglobulin lozenge for 3 months, according to a pilot study published in Clinical and Translational Allergy.